Elsevier Inc.

SHERPA: Unknown

People

  1. O'Reilly
    O'Reilly
  2. Giralt
    Giralt
  3. Perales
    Perales
  4. Castro-Malaspina
    Castro-Malaspina
  5. Devlin
    Devlin
  6. Shah
    Shah
  7. Tamari
    Tamari
  8. Papadopoulos
    Papadopoulos
  9. Scordo
    Scordo
  10. Kernan
    Kernan

Groups

  1. Center for Hematologic Malignancies (22)
  2. Department of Medicine (22)
  3. GSK Faculty (22)
  4. Immunology Program Faculty (22)
  5. Nursing (22)
  6. Sloan Kettering Institute Faculty (22)
  7. Hematologic Malignancies, Division of (19)
  8. Bone Marrow Transplant (18)
  9. Pediatrics, Department of (17)
  10. Stem Cell Transplantation and Cellular Therapy Service (16)
Search Within
  1. "Immunology Program Faculty"
  2. "Center for Hematologic Malignancies"
  3. "Nursing"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (5)
Groups
  1. Center for Hematologic Malignancies (22)
  2. Department of Medicine (22)
  3. GSK Faculty (22)
  4. Immunology Program Faculty (22)
  5. Nursing (22)
  6. Sloan Kettering Institute Faculty (22)

More Groups

People
  1. Richard O'Reilly (15)
  2. Sergio Giralt (13)
  3. Miguel-Angel Perales (12)
  4. Hugo Castro-Malaspina (11)
  5. Molly Maloy (11)
  6. Sean Devlin (11)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2019 (3)
  4. 2018 (2)
  5. 2017 (6)
  6. 2016 (3)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (20)
  2. Clinical Lymphoma, Myeloma and Leukemia (2)

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM is feasible and associated with reduction in insulin and leptin levels
    Meeting Abstract

    Shah, U.; Castro, F.; Anuraj, A.; Blaslov, J.; Adintori, P.; Derkach, A.; Pollak, M.; Maclachlan, K.; Mailankody, S.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Intestinal microbiome analyses identify biomarkers for patient response to CAR T cell therapy
    Meeting Abstract

    Smith, M.; Littmann, E.; Slingerland, J.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Peled, J. U.; Park, J.; O'Cearbhaill, R.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Efficacy of donor and 'third party' (Tabelecleucel) EBV-specific T cells for treatment of central nervous system (CNS) EBV-PTLD
    Meeting Abstract

    Prockop, S. E.; Suser, S.; Doubrovina, E. S.; Castro-Malaspina, H.; Papadopoulos, E. B.; Sauter, C. S.; Young, J. W.; Szenes, V.; Slocum, A.; Baroudy, K.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Rituximab use, immune reconstitution, and vaccination after ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Preston, E. V.; Malard, F.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; Smith, K.; Maslak, P.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Effects of late toxicities on outcomes in long-term survivors of ex-vivo CD34(+)-selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Toxicities and outcomes in the first year after ex-vivo CD34+ selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies
    Meeting Abstract

    Kosuri, S.; Herrera, D. A. A.; Scordo, M.; Shah, G. L.; Devlin, S. M.; Maloy, M.; Nieves, J.; Cho, C.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Post-transplant toxicities and outcomes in long-term survivors of ex-vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M.; Nieves, J.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Immune-mediated hemolytic anemia (IMHA) and immune thrombocytopenia (ITP) after ex-vivo CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Adrianzen Herrera, D. A.; Hsu, M.; Devlin, S. M.; Maloy, M.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save